Loading clinical trials...
Loading clinical trials...
Implementing Anti-Retroviral Therapy in Resource-Constrained Settings: A Randomized Controlled Trial to Assess the Effect of Integrated Tuberculosis and HIV Care on the Incidence of AIDS-Defining Conditions or Mortality in Subjects Co-Infected With Tuberculosis and HIV
Conditions
Interventions
Didanosine
Efavirenz
+2 more
Locations
2
South Africa
King Edward VIII Hospital
KwaKhangela, Durban, South Africa
Prince Cyril Zulu CDC
KwaKhangela, Durban, South Africa
Start Date
August 1, 2009
Last Updated
March 29, 2010
NCT06192160
NCT05947890
NCT05989802
NCT04142047
NCT06694805
NCT06272812
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions